ClinicalTrials.govpublic full text
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans
insulin resistance, dyslipidemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 432847
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.